IHH Healthcare Berhad (Q0F) SEC News Sept. 03, 2025, 09:52 UTC 0 0 comments Employee Stock Option/ Share Scheme: NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) - OTHER ISSUE OF SECURITIES Comment Full text
IHH Healthcare Berhad (Q0F) SEC News Sept. 03, 2025, 09:21 UTC 0 0 comments General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016 Comment Full text
Shattuck Labs Inc (STTK) SEC News Sept. 03, 2025, 01:53 UTC 2 0 comments New Form SCHEDULE 13D - Shattuck Labs, Inc. Filed: 2025-09-02 AccNo: 0000947871-25-000841 Size: 30 KB Comment Full text
Shattuck Labs Inc (STTK) SEC News Sept. 03, 2025, 01:52 UTC 0 1 comments Director ORBIMED ADVISORS LLC 🟢 acquired 36.9M shares (4 derivative) of Shattuck Labs, Inc. (STTK) at $1.08 ($25.5M) Transaction Date: Aug 25, 2025 | Filing ID: 000840 Comment Full text
Shattuck Labs Inc (STTK) SEC News Sept. 03, 2025, 01:50 UTC 0 1 comments Director Ashiya Mona 🟢 acquired 36.9M shares (4 derivative) of Shattuck Labs, Inc. (STTK) at $1.08 ($25.5M) Transaction Date: Aug 25, 2025 | Filing ID: 000839 Comment Full text
Shattuck Labs Inc (STTK) SEC News Sept. 03, 2025, 01:49 UTC 1 0 comments New Form 3 - Shattuck Labs, Inc. Filed: 2025-09-02 AccNo: 0000947871-25-000838 Size: 6 KB Comment Full text
IRIDEX Corporation (IRIX) SEC News Sept. 03, 2025, 01:35 UTC 0 1 comments Dizon Romeo R 🟢 acquired 625 shares of IRIDEX CORP (IRIX) at $1.34 Transaction Date: Sep 02, 2025 | Filing ID: 112648 Comment Full text
Natera Inc (NTRA) SEC News Sept. 03, 2025, 01:05 UTC 0 1 comments Chapman Rowan E 🟡 adjusted position in 187 shares of Natera, Inc. (NTRA) at $166.99 Transaction Date: Jun 27, 2025 | Filing ID: 023477 Comment Full text
Roivant Sciences Ltd (ROIV) SEC News Sept. 03, 2025, 01:00 UTC 0 1 comments Pulik Richard 🔴 sold 2.3K shares of Roivant Sciences Ltd. (ROIV) at $11.94 Transaction Date: Aug 28, 2025 | Filing ID: 033687 Comment Full text
Mineralys Therapeutics Inc (MLYS) SEC News Sept. 03, 2025, 00:52 UTC 0 0 comments New Form S-3MEF - Mineralys Therapeutics, Inc. Filed: 2025-09-02 AccNo: 0001933414-25-000112 Size: 278 KB Comment Full text